Cargando…
The advantages of drug treatment with statins in patients with SARS-CoV-2 infection
On 11 March 2020 the World Health Organization (WHO) declared a status of global pandemic caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019, COVID-19). The pandemic is currently underway, and to date has caused approximately 2.42 million deaths...
Autores principales: | Ferrara, Francesco, Vitiello, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006129/ https://www.ncbi.nlm.nih.gov/pubmed/33779831 http://dx.doi.org/10.1007/s00508-021-01845-8 |
Ejemplares similares
-
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state
por: Vitiello, Antonio, et al.
Publicado: (2021) -
Drugs acting on the renin–angiotensin system and SARS-CoV-2
por: Vitiello, Antonio, et al.
Publicado: (2021) -
The direct correlation between microbiota and SARS-CoV-2 infectious disease
por: Vitiello, Antonio, et al.
Publicado: (2023) -
Association between microbiota and immune response to Sars-CoV-2 infection
por: Vitiello, A., et al.
Publicado: (2023) -
The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021)